212 related articles for article (PubMed ID: 38113335)
21. Oncogenically active MYD88 mutations in human lymphoma.
Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
[TBL] [Abstract][Full Text] [Related]
22. The kinase activity of IL-1 receptor-associated kinase 4 is required for interleukin-1 receptor/toll-like receptor-induced TAK1-dependent NFkappaB activation.
Fraczek J; Kim TW; Xiao H; Yao J; Wen Q; Li Y; Casanova JL; Pryjma J; Li X
J Biol Chem; 2008 Nov; 283(46):31697-705. PubMed ID: 18794297
[TBL] [Abstract][Full Text] [Related]
23. Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts.
Della Mina E; Borghesi A; Zhou H; Bougarn S; Boughorbel S; Israel L; Meloni I; Chrabieh M; Ling Y; Itan Y; Renieri A; Mazzucchelli I; Basso S; Pavone P; Falsaperla R; Ciccone R; Cerbo RM; Stronati M; Picard C; Zuffardi O; Abel L; Chaussabel D; Marr N; Li X; Casanova JL; Puel A
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E514-E523. PubMed ID: 28069966
[TBL] [Abstract][Full Text] [Related]
24. Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling.
Strickson S; Emmerich CH; Goh ETH; Zhang J; Kelsall IR; Macartney T; Hastie CJ; Knebel A; Peggie M; Marchesi F; Arthur JSC; Cohen P
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):E3481-E3489. PubMed ID: 28404732
[TBL] [Abstract][Full Text] [Related]
25. IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal).
Dunne A; Carpenter S; Brikos C; Gray P; Strelow A; Wesche H; Morrice N; O'Neill LA
J Biol Chem; 2010 Jun; 285(24):18276-82. PubMed ID: 20400509
[TBL] [Abstract][Full Text] [Related]
26. Both IRAK3 and IRAK1 Activate the MyD88-TRAF6 Pathway in Zebrafish.
Weng P; Lan M; Zhang H; Fan H; Wang X; Ran C; Yue Z; Hu J; Xu A; Huang S
J Immunol; 2024 Jun; ():. PubMed ID: 38847613
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.
Abend JR; Ramalingam D; Kieffer-Kwon P; Uldrick TS; Yarchoan R; Ziegelbauer JM
J Virol; 2012 Nov; 86(21):11663-74. PubMed ID: 22896623
[TBL] [Abstract][Full Text] [Related]
28. Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types.
Chiang EY; Yu X; Grogan JL
J Immunol; 2011 Jan; 186(2):1279-88. PubMed ID: 21160042
[TBL] [Abstract][Full Text] [Related]
29. The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways.
Pereira M; Durso DF; Bryant CE; Kurt-Jones EA; Silverman N; Golenbock DT; Gazzinelli RT
Cell Rep; 2022 Aug; 40(7):111225. PubMed ID: 35977521
[TBL] [Abstract][Full Text] [Related]
30. Clinical IRAK4 deficiency caused by homozygosity for the novel
Jia A; James E; Lu HY; Sharma M; Modi BP; Biggs CM; Hildebrand KJ; Chomyn A; Erdle S; Kular H; Turvey SE
Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32532880
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.
Sun J; Li N; Oh KS; Dutta B; Vayttaden SJ; Lin B; Ebert TS; De Nardo D; Davis J; Bagirzadeh R; Lounsbury NW; Pasare C; Latz E; Hornung V; Fraser ID
Sci Signal; 2016 Jan; 9(409):ra3. PubMed ID: 26732763
[TBL] [Abstract][Full Text] [Related]
32. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
33. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression.
Xiong Y; Qiu F; Piao W; Song C; Wahl LM; Medvedev AE
J Biol Chem; 2011 Mar; 286(10):7905-7916. PubMed ID: 21220427
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Pellino2, a substrate of IRAK1 and IRAK4.
Strelow A; Kollewe C; Wesche H
FEBS Lett; 2003 Jul; 547(1-3):157-61. PubMed ID: 12860405
[TBL] [Abstract][Full Text] [Related]
35. Interleukin Receptor Associated Kinase 1 Signaling and Its Association with Cardiovascular Diseases.
Zheng Y; He JQ
Rev Cardiovasc Med; 2022 Mar; 23(3):97. PubMed ID: 35345264
[TBL] [Abstract][Full Text] [Related]
36. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
Kawagoe T; Sato S; Matsushita K; Kato H; Matsui K; Kumagai Y; Saitoh T; Kawai T; Takeuchi O; Akira S
Nat Immunol; 2008 Jun; 9(6):684-91. PubMed ID: 18438411
[TBL] [Abstract][Full Text] [Related]
37. Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1.
Choi KC; Lee YS; Lim S; Choi HK; Lee CH; Lee EK; Hong S; Kim IH; Kim SJ; Park SH
Nat Immunol; 2006 Oct; 7(10):1057-65. PubMed ID: 16951688
[TBL] [Abstract][Full Text] [Related]
38. Functional Variation of IL-1R-Associated Kinases in the Conserved MyD88-TRAF6 Pathway during Evolution.
Yan X; Chen S; Huang H; Peng T; Lan M; Yang X; Dong M; Chen S; Xu A; Huang S
J Immunol; 2020 Feb; 204(4):832-843. PubMed ID: 31915260
[TBL] [Abstract][Full Text] [Related]
39. Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R/TLR signaling.
Lee YS; Kim JH; Kim ST; Kwon JY; Hong S; Kim SJ; Park SH
Biochem Biophys Res Commun; 2010 Mar; 393(4):836-43. PubMed ID: 20171181
[TBL] [Abstract][Full Text] [Related]
40. Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML.
Bennett J; Ishikawa C; Agarwal P; Yeung J; Sampson A; Uible E; Vick E; Bolanos LC; Hueneman K; Wunderlich M; Kolt A; Choi K; Volk A; Greis KD; Rosenbaum J; Hoyt SB; Thomas CJ; Starczynowski DT
Blood; 2023 Sep; 142(11):989-1007. PubMed ID: 37172199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
